Khanuja Parvinderjit S. 4
4 · SELECT MEDICAL HOLDINGS CORP · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Select Medical (SEM) Director Khanuja Parvinderjit S. Sells 79,124 Shares
What Happened Khanuja Parvinderjit S., a director of Select Medical Holdings Corp. (SEM), had 79,124 shares disposed to the issuer as part of a merger on 2026-06-30. Each share was converted into $16.50 in cash under the Merger Agreement, producing total consideration of $1,305,546. This disposition (transaction code D) was the cash-out of holdings in connection with the merger—not an open-market sale.
Key Details
- Transaction date and price: 2026-06-30, 79,124 shares at $16.50 per share.
- Total proceeds: $1,305,546.
- Transaction type/code: Disposition to issuer (D) — conversion under the Merger Agreement.
- Footnote highlights:
- F1: Conversion pursuant to the Merger Agreement (each pre-merger share converted into $16.50 cash).
- F2: Unvested restricted shares vested immediately prior to the merger and were converted into the same cash consideration, net of applicable tax withholdings.
- Shares owned after transaction: Not stated in this filing.
- Filing timeliness: Report covers period ended 2026-06-30 and was filed 2026-07-01 (no late filing indicated).
Context This was a merger-related cash conversion of existing and previously unvested restricted shares into merger consideration. Such dispositions are routine outcomes of corporate mergers and reflect the deal terms rather than an individual trading decision.
Insider Transaction Report
- Disposition to Issuer
Common Stock
[F1][F2]2026-06-30$16.50/sh−79,124$1,305,546→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
- [F2]Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.